MedTrace Logo

Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.

NCT03050983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2020-09-30

No results posted yet for this study

Summary

Single site prospective observational nested study of bedside CS20p monitor on the GCF impeded into a retrospective review of the frequency of escalation of care with intermittent vitals signs compared to continuous respiratory monitoring.

Conditions

  • Respiratory Depression
  • Respiratory Insufficiency

Interventions

DEVICE

IPI

Enable the IPI algorithm and IPI alarm algorithm

Sponsors & Collaborators

  • Medtronic - MITG

    lead INDUSTRY

Principal Investigators

  • Liza Weavind, MBBCh,FCCM,MMHC · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2018-01-26
Completion
2020-09-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03050983 on ClinicalTrials.gov